RIGL 最新季度財報
公佈日期8/4/2026
實際每股收益(美元)0.93
實際營收(美元)78.70M
本頁面提供詳細的 Rigel Pharmaceuticals Inc 財報數據,包括最新財報、下一次財報發佈日期、歷史數據,以及 Rigel Pharmaceuticals Inc 財報法說會相關新聞。
| 發布日期 | 報告期末 | 每股收益/預測值 | 營收/預測值 | 每股收益超出預期幅度% | 營收超出預期幅度% |
|---|---|---|---|---|---|
| 8/4/2026 | 06/2026 | 0.93/0.62 | 78.70M/69.46M | 50.41% | 13.30% |
| 5/5/2026 | 03/2026 | 0.47/0.76 | 58.82M/64.22M | -38.16% | -8.40% |
| 3/3/2026 | 12/2025 | 14.72/1.25 | 69.80M/68.70M | 1080.60% | 1.60% |
| 11/4/2025 | 09/2025 | 1.55/0.85 | 69.46M/61.88M | 80.96% | 12.25% |
| 8/5/2025 | 06/2025 | 3.33/2.58 | 101.69M/88.95M | 29.19% | 14.32% |
| 5/6/2025 | 03/2025 | 0.64/0.09 | 53.33M/43.87M | 620.56% | 21.56% |
| 3/4/2025 | 12/2024 | 0.81/0.47 | 57.60M/51.73M | 74.01% | 11.34% |
| 11/7/2024 | 09/2024 | 0.71/0.06 | 55.31M/41.93M | 1109.91% | 31.91% |